Jasna Kriz
Université Laval
H-index: 42
North America-Canada
Top articles of Jasna Kriz
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Dysregulation of Adipocyte Response in Amyotrophic Lateral Sclerosis: Developing the Humanized in Vitro Model System to Screen for Immuno-metabolic Molecular Signatures (P5-11.001) | Vézina Alexandre Vincent Picher-Martel Hejer Boutej Angela Genge Nicolas Dupre | 2024/4/14 | |
Chronically activated microglia in ALS gradually lose their immune functions and develop unconventional proteome | Glia | Romina Barreto‐Núñez Louis‐Charles Béland Hejer Boutej Vincent Picher‐Martel Nicolas Dupré | 2024/4/5 |
Targeting SRSF3 restores immune mRNA translation in microglia/macrophages following cerebral ischemia | Molecular Therapy | Reza Rahimian Revathy Guruswamy Hejer Boutej Pierre Cordeau Yuan Cheng Weng | 2024/1/8 |
Distinct plasma immune profile in ALS implicates sTNFR-II in pAMPK/leptin homeostasis | International Journal of Molecular Sciences | Vincent Picher-Martel Hejer Boutej Alexandre Vézina Pierre Cordeau Hannah Kaneb | 2023/3/7 |
Therapeutic trial of anle138b in mouse models of genetic prion disease | Journal of Virology | Sonia M Vallabh Dan Zou Rose Pitstick Jill O’Moore Janet Peters | 2023/2/28 |
CD36 neutralisation blunts TLR2-IRF7 but not IRF3 pathway in neonatal mouse brain and immature human microglia following innate immune challenge | Scientific Reports | Shruti Gururaj Gadagkar Melanie Lalancette-Hébert Sai Sampath Thammisetty Zinaida S Vexler Jasna Kriz | 2023/2/9 |
Translational profiling identifies sex-specific metabolic and epigenetic reprogramming of cortical microglia/macrophages in APPPS1-21 mice with an antibiotic-perturbed-microbiome | Molecular Neurodegeneration | Shabana M Shaik Yajun Cao Joseph V Gogola Hemraj B Dodiya Xulun Zhang | 2023/12/16 |
Emerging trends in the field of inflammation and proteinopathy in ALS/FTD spectrum disorder | Fabiola De Marchi Toni Franjkic Paride Schito Tommaso Russo Jerneja Nimac | 2023/5/31 | |
BRAIN COMMUNICATIONS AIN COMMUNICATIONS | LA Benjamin E Lim M Sokolska J Markus T Zaletel | 2022 | |
Use of SRSF3 agents for the treatment and/or prevention of neurological conditions, cancer, bacterial infections or viral infections | 2022/12/20 | ||
Translational profiling identifies sex‐specific metabolic and epigenetic reprogramming of microglia in cerebral amyloidosis models with an antibiotic‐altered gut microbiome | Alzheimer's & Dementia | Shabana M Shaik Yajun Cao Hemraj B Dodiya Xulun Zhang Hejer Boutej | 2022/12 |
Changes in Leptin, CCL16 and sTNF-RII as a Distinctive Plasma Immune Profile in Patients with Fast Progressing ALS (1276) | Vincent Picher-Martel Hejer Boutej Pierre Cordeau Hannah Kaneb Jean-Pierre Julien | 2021/4/13 | |
Targeting TDP-43 pathology alleviates cognitive and motor deficits caused by chronic cerebral hypoperfusion | Neurotherapeutics | Sai Sampath Thammisetty Laurence Renaud Vincent Picher-Martel Yuan Cheng Weng Frédéric Calon | 2021/4/1 |
Induction of autophagy mitigates TDP-43 pathology and translational repression of neurofilament mRNAs in mouse models of ALS/FTD | Molecular Neurodegeneration | Sunny Kumar Daniel Phaneuf Pierre Cordeau Hejer Boutej Jasna Kriz | 2021/12 |
Differential expression patterns of TDP-43 in single moderate versus repetitive mild traumatic brain injury in mice | International journal of molecular sciences | Tamara Janković Petra Dolenec Jelena Rajič Bumber Nika Gržeta Jasna Kriz | 2021/11/11 |
GP. 2 Changes in Leptin, CCL16 and sTNF-RII as a distinctive plasma immune profile in patients with fast progressing ALS | Canadian Journal of Neurological Sciences | V Picher-Martel H Boutej P Cordeau H Kaneb J Julien | 2021/11 |
Microglia‐derived galectin‐3 in neuroinflammation; a bittersweet ligand? | Reza Rahimian Louis‐Charles Béland Sachiko Sato Jasna Kriz | 2021/7 | |
Immunity in amyotrophic lateral sclerosis: Blurred lines between excessive inflammation and inefficient immune responses | Louis-Charles Béland Andrea Markovinovic Hrvoje Jakovac Fabiola De Marchi Ervina Bilic | 2020 | |
Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints | Nucleic acids research | Eric Vallabh Minikel Hien T Zhao Jason Le Jill O’Moore Rose Pitstick | 2020/11/4 |
Transmission of ALS pathogenesis by the cerebrospinal fluid | Acta neuropathologica communications | Pooja Shree Mishra Hejer Boutej Geneviève Soucy Christine Bareil Sunny Kumar | 2020/5/7 |
